Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 426218, 10 pages
http://dx.doi.org/10.1155/2010/426218
Review Article

Circulating Tumor Cell Analysis: Technical and Statistical Considerations for Application to the Clinic

1London Regional Cancer Program, London Health Sciences Centre, London, ON, N6A 5W9, Canada
2Lawson Health Research Institute, London, ON, Canada N6A 4V2
3Department of Oncology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada N6A 3K7
4Department of Anatomy & Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada N6A 3K7
5Special Hematology/Flow Cytometry, London Health Sciences Centre, London, ON, Canada N6A 5W9

Received 30 April 2009; Accepted 15 September 2009

Academic Editor: Vassilis Georgoulias

Copyright © 2010 Alison L. Allan and Michael Keeney. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and T. Murray, “Cancer statistics, 2008,” CA: A Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Canadian Cancer Statistics 2008, National Cancer Institute of Canada: Toronto, Canada, 2008http://www.cancer.ca.
  3. A. F. Chambers, A. C. Groom, and I. C. MacDonald, “Dissemination and growth of cancer cells in metastatic sites,” Nature Reviews Cancer, vol. 2, no. 8, pp. 563–572, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Pantel and R. H. Brakenhoff, “Dissecting the metastatic cascade,” Nature Reviews Cancer, vol. 4, no. 6, pp. 448–456, 2004. View at Google Scholar · View at Scopus
  5. A. F. Chambers, G. N. Naumov, H. J. Varghese, K. V. Nadkarni, I. C. MacDonald, and A. C. Groom, “Critical steps in hematogenous metastasis: an overview,” Surgical Oncology Clinics of North America, vol. 10, no. 2, pp. 243–255, 2001. View at Google Scholar · View at Scopus
  6. I. J. Fidler, “7th Jan Waldenstrom Lecture. The biology of human cancer metastasis,” Acta Oncologica, vol. 30, no. 6, pp. 668–675, 1991. View at Google Scholar · View at Scopus
  7. E. C. Woodhouse, R. F. Chuaqui, and L. A. Liotta, “General mechanisms of metastasis,” Cancer, vol. 80, supplement 8, pp. 1529–1537, 1997. View at Google Scholar · View at Scopus
  8. M. A. Swartz and M. Skobe, “Lymphatic function, lymphangiogenesis, and cancer metastasis,” Microscopy Research and Technique, vol. 55, no. 2, pp. 92–99, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Alix-Panabieres, V. Muller, and K. Pantel, “Current status in human breast cancer micrometastasis,” Current Opinion in Oncology, vol. 19, no. 6, pp. 558–563, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Dawood and M. Cristofanilli, “Integrating circulating tumor cell assays into the management of breast cancer,” Current Treatment Options in Oncology, vol. 8, no. 1, pp. 89–95, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Pantel, R. H. Brakenhoff, and B. Brandt, “Detection, clinical relevance and specific biological properties of disseminating tumour cells,” Nature Reviews Cancer, vol. 8, no. 5, pp. 329–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Riethdorf and K. Pantel, “Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization,” Pathobiology, vol. 75, no. 2, pp. 140–148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. B. Smerage and D. F. Hayes, “The prognostic implications of circulating tumor cells in patients with breast cancer,” Cancer Investigation, vol. 26, no. 2, pp. 109–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Paterlini-Brechot and N. L. Benali, “Circulating tumor cells (CTC) detection: clinical impact and future directions,” Cancer Letters, vol. 253, no. 2, pp. 180–204, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. R. Ashworth, “A case of cancer in which cells similar to those in the tumours were seen in the blood after death,” The Medical Journal of Australia, vol. 14, pp. 146–149, 1869. View at Google Scholar
  16. P. Bossolasco, C. Ricci, G. Farina et al., “Detection of micrometastatic cells in breast cancer by RT-PCR for the mammaglobin gene,” Cancer Detection and Prevention, vol. 26, no. 1, pp. 60–63, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. V. V. Iakovlev, R. S. Goswami, J. Vecchiarelli, N. C. R. Arneson, and S. J. Done, “Quantitative detection of circulating epithelial cells by Q-RT-PCR,” Breast Cancer Research and Treatment, vol. 107, no. 1, pp. 145–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Xenidis, M. Perraki, M. Kafousi et al., “Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients,” Journal of Clinical Oncology, vol. 24, no. 23, pp. 3756–3762, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Cabioglu, A. Igci, E. O. Yildirim et al., “An ultrasensitive tumor enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer,” American Journal of Surgery, vol. 184, no. 5, pp. 414–417, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Cruz, J. Ciudad, J. J. Cruz et al., “Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples,” American Journal of Clinical Pathology, vol. 123, no. 1, pp. 66–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. J. Simpson, M. Vachula, M. J. Kennedy et al., “Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry,” Experimental Hematology, vol. 23, no. 10, pp. 1062–1068, 1995. View at Google Scholar · View at Scopus
  22. S. Braun, F. D. Vogl, B. Naume et al., “A pooled analysis of bone marrow micrometastasis in breast cancer,” The New England Journal of Medicine, vol. 353, no. 8, pp. 793–802, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Pachmann, O. Camara, A. Kavallaris et al., “Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse,” Journal of Clinical Oncology, vol. 26, no. 8, pp. 1208–1215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. E. Ring, L. Zabaglo, M. G. Ormerod, I. E. Smith, and M. Dowsett, “Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques,” British Journal of Cancer, vol. 92, no. 5, pp. 906–912, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Zabaglo, M. G. Ormerod, M. Parton, A. Ring, I. E. Smith, and M. Dowsett, “Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells,” Cytometry A, vol. 55, no. 2, pp. 102–108, 2003. View at Google Scholar · View at Scopus
  26. M. Cristofanilli, G. T. Budd, M. J. Ellis et al., “Circulating tumor cells, disease progression, and survival in metastatic breast cancer,” The The New England Journal of Medicine, vol. 351, no. 8, pp. 781–791, 2004. View at Google Scholar
  27. S. Riethdorf, H. Fritsche, V. Muller et al., “Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the cell search system,” Clinical Cancer Research, vol. 13, no. 3, pp. 920–928, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Nagrath, L. V. Sequist, S. Maheswaran et al., “Isolation of rare circulating tumour cells in cancer patients by microchip technology,” Nature, vol. 450, no. 7173, pp. 1235–1239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. G. J. Tibbe, M. C. Miller, and L. W. Terstappen, “Statistical considerations for enumeration of circulating tumor cells,” Cytometry A, vol. 71, no. 3, pp. 154–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. A. A. Ross, B. W. Cooper, H. M. Lazarus et al., “Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques,” Blood, vol. 82, no. 9, pp. 2605–2610, 1993. View at Google Scholar · View at Scopus
  31. S. Sleijfer, J.-W. Gratama, A. M. Sieuwerts, J. Kraan, J. W. M. Martens, and J. A. Foekens, “Circulating tumour cell detection on its way to routine diagnostic implementation?” European Journal of Cancer, vol. 43, no. 18, pp. 2645–2650, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Goodale, C. Phay, W. Brown et al., “Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer,” Cytometry B, vol. 76, no. 2, pp. 107–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Goodale, C. Phay, C. O. Postenka, M. Keeney, and A. L. Allan, “Characterization of tumor cell dissemination patterns in preclinlcal models of cancer metastasis using flow cytometry and laser scanning cytometry,” Cytometry A, vol. 75, no. 4, pp. 344–355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Google Scholar · View at Scopus
  35. D. F. Hayes and J. R. Smerage, “Is there a role for circulating tumor cells in the management of breast cancer?” Clinical Cancer Research, vol. 14, no. 12, pp. 3646–3650, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Xi, D. G. Nicastri, T. El-Hefnawy et al., “Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers,” Clinical Chemistry, vol. 53, no. 7, pp. 1206–1215, 2007. View at Google Scholar
  37. R. Jung, W. Kruger, S. Hosch et al., “Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro,” British Journal of Cancer, vol. 78, no. 9, pp. 1194–1198, 1998. View at Google Scholar · View at Scopus
  38. K. Polyak and R. A. Weinberg, “Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits,” Nature Reviews Cancer, vol. 9, no. 4, pp. 265–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. P. Thiery and J. P. Sleeman, “Complex networks orchestrate epithelial-mesenchymal transitions,” Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 131–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Yang and R. A. Weinberg, “Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis,” Developmental Cell, vol. 14, no. 6, pp. 818–829, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. M. Sieuwerts, J. Kraan, J. Bolt et al., “Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells,” Journal of the National Cancer Institute, vol. 101, no. 1, pp. 61–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. A. L. Allan, S. A. Vantyghem, A. B. Tuck et al., “Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry,” Cytometry A, vol. 65, no. 1, pp. 4–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Cristofanilli, J. Reuben, and J. Uhr, “Circulating tumor cells in breast cancer: fiction or reality?” Journal of Clinical Oncology, vol. 26, no. 21, pp. 3656–3657, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Keeney, D. Barnett, and J. W. Gratama, “Impact of standardization on clinical cell analysis by flow cytometry,” Journal of Biological Regulators and Homeostatic Agents, vol. 18, no. 3-4, pp. 305–312, 2004. View at Google Scholar · View at Scopus
  45. J. S. de Bono, H. I. Scher, R. B. Montgomery et al., “Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer,” Clinical Cancer Research, vol. 14, no. 19, pp. 6302–6309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. R. E. Smith Jr., “Trends in recommendations for myelosuppressive chemotherapy for the treatment of solid tumors,” Journal of the National Comprehensive Cancer Network, vol. 4, no. 7, pp. 649–658, 2006. View at Google Scholar · View at Scopus
  47. S. Zheng, H. Lin, J.-Q. Liu et al., “Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells,” Journal of Chromatography A, vol. 1162, no. 2, pp. 154–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Ring, I. E. Smith, and M. Dowsett, “Circulating tumour cells in breast cancer,” The Lancet Oncology, vol. 5, no. 2, pp. 79–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Pachmann, P. Heiss, U. Demel, and G. Tilz, “Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC),” Clinical Chemistry and Laboratory Medicine, vol. 39, no. 9, pp. 811–817, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. S.-K. Kraeft, R. Sutherland, L. Gravelin et al., “Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system,” Clinical Cancer Research, vol. 6, no. 2, pp. 434–442, 2000. View at Google Scholar · View at Scopus
  51. W. He, H. Wang, L. C. Hartmann, J.-X. Cheng, and P. S. Low, “In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 28, pp. 11760–11765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. S. J. Cohen, C. J. A. Punt, N. Iannotti et al., “Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer,” Journal of Clinical Oncology, vol. 26, no. 19, pp. 3213–3221, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. D. C. Danila, G. Heller, G. A. Gignac et al., “Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer,” Clinical Cancer Research, vol. 13, no. 23, pp. 7053–7058, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Alix-Panabieres, J.-P. Vendrell, O. Pelle et al., “Detection and characterization of putative metastatic precursor cells in cancer patients,” Clinical Chemistry, vol. 53, no. 3, pp. 537–539, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. E. N. Stathopoulos, E. Sanidas, M. Kafousi et al., “Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes,” Annals of Oncology, vol. 16, no. 2, pp. 240–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Stathopoulou, A. Gizi, M. Perraki et al., “Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system,” Clinical Cancer Research, vol. 9, no. 14, pp. 5145–5151, 2003. View at Google Scholar · View at Scopus
  57. A. Stathopoulou, M. Ntoulia, M. Perraki et al., “A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer,” International Journal of Cancer, vol. 119, no. 7, pp. 1654–1659, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Stathopoulou, I. Vlachonikolis, D. Mavroudis et al., “Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance,” Journal of Clinical Oncology, vol. 20, no. 16, pp. 3404–3412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. T.G. Allen-Mersh, T. K. McCullough, H. Patel, R. Q. Wharton, C. Glover, and S. K. Jonas, “Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma,” British Journal of Surgery, vol. 94, no. 1, pp. 96–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Helo, A. M. Cronin, D. C. Danila et al., “Circulating prostate tumor cells detected by Reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival,” Clinical Chemistry, vol. 55, no. 4, pp. 765–773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Harris, H. Fritsche, R. Mennel et al., “American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer,” Journal of Clinical Oncology, vol. 25, no. 33, pp. 5287–5312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. W. J. Allard, J. Matera, M. C. Miller et al., “Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases,” Clinical Cancer Research, vol. 10, no. 20, pp. 6897–6904, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. D. F. Hayes, M. Cristofanilli, G. T. Budd et al., “Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival,” Clinical Cancer Research, vol. 12, no. 14, part 1, pp. 4218–4224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. G. T. Budd, M. Cristofanilli, M. J. Ellis et al., “Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer,” Clinical Cancer Research, vol. 12, no. 21, pp. 6403–6409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. Southwestern Oncology Group, 2008, http://www.swog.org.
  66. S. Meng, D. Tripathy, S. Shete et al., “HER-2 gene amplification can be acquired as breast cancer progresses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 25, pp. 9393–9398, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. J. R. de la Haba-Rodriguez, M. Ruiz Borrego, A. Gomez Espana et al., “Comparative study of the immunohistochemical phenotype in breast cancer and its lymph node metastatic location,” Cancer Investigation, vol. 22, no. 2, pp. 219–224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Gangnus, S. Langer, E. Breit, K. Pantel, and M. R. Speicher, “Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients,” Clinical Cancer Research, vol. 10, no. 10, pp. 3457–3464, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. C. A. Klein, T. J. Blankenstein, O. Schmidt-Kittler et al., “Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer,” The Lancet, vol. 360, no. 9334, pp. 683–689, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. F. Cardoso, A. Di Leo, D. Larsimont et al., “Evaluation of HER2, p53, bcl-2, topoisomerase II-a, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes,” Annals of Oncology, vol. 12, no. 5, pp. 615–620, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Cristofanilli and J. Mendelsohn, “Circulating tumor cells in breast cancer: advanced tools for “tailored” therapy?” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17073–17074, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Meng, D. Tripathy, S. Shete et al., “uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17361–17365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. J. S. de Bono, G. Attard, A. Adjei et al., “Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor,” Clinical Cancer Research, vol. 13, no. 12, pp. 3611–3616, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Maheswaran, L. V. Sequist, S. Nagrath et al., “Detection of mutations in EGFR in circulating lung-cancer cells,” The The New England Journal of Medicine, vol. 359, no. 4, pp. 366–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. R. I. Payne, E. Yague, M. J. Slade et al., “Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients,” Pharmacogenomics, vol. 10, no. 1, pp. 51–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. J. F. Swennenhuis, A. G. Tibbe, R. Levink, R. C. Sipkema, and L. W. Terstappen, “Characterization of circulating tumor cells by fluorescence in situ hybridization,” Cytometry A, vol. 75, no. 6, pp. 520–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. D. A. Smirnov, D. R. Zweitzig, B. W. Foulk et al., “Global gene expression profiling of circulating tumor cells,” Cancer Research, vol. 65, no. 12, pp. 4993–4997, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. M. A. Leversha, J. Han, Z. Asgari et al., “Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer,” Clinical Cancer Research, vol. 15, no. 6, pp. 2091–2097, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. D. R. Shaffer, M. A. Leversha, D. C. Danila et al., “Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer,” Clinical Cancer Research, vol. 13, no. 7, pp. 2023–2029, 2007. View at Publisher · View at Google Scholar · View at Scopus